{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T06:27:21Z","timestamp":1786516041268,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004270","name":"Royal Institute of Technology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004270","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-026-06301-2","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:26:24Z","timestamp":1782278784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trimerization of CD40L-specific affibody molecules using collagen domains enhances target binding and CD40 blockade"],"prefix":"10.1007","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0274-063X","authenticated-orcid":false,"given":"Cornelia","family":"Westerberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6803-8377","authenticated-orcid":false,"given":"Chiara","family":"Sorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Al-Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3941-1600","authenticated-orcid":false,"given":"Hanna","family":"Mehari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotta","family":"Preger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"St\u00e5hl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0756-889X","authenticated-orcid":false,"given":"Maja","family":"Jagodic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9423-0541","authenticated-orcid":false,"given":"John","family":"L\u00f6fblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"6301_CR1","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1126\/science.ade6949","volume":"385","author":"JD Laman","year":"2024","unstructured":"Laman JD, Molloy M, Noelle RJ (2024) Switching off autoimmunity. Science 385:827\u2013829. https:\/\/doi.org\/10.1126\/science.ade6949","journal-title":"Science"},{"issue":"711","key":"6301_CR2","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1126\/scitranslmed.adf6376","volume":"15","author":"IJ Anwar","year":"2023","unstructured":"Anwar IJ, Berman DM, Delaura I et al (2023) The anti-CD40L monoclonal antibody AT-1501 promotes islet and kidney allograft survival and function in nonhuman primates. Sci Transl Med 15:711. https:\/\/doi.org\/10.1126\/scitranslmed.adf6376","journal-title":"Sci Transl Med"},{"key":"6301_CR3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","volume":"229","author":"R Elgueta","year":"2009","unstructured":"Elgueta R, Benson MJ, De Vries VC et al (2009) Molecular mechanism and function of CD40\/CD40L engagement in the immune system. Immunol Rev 229:152\u2013172. https:\/\/doi.org\/10.1111\/j.1600-065X.2009.00782.x","journal-title":"Immunol Rev"},{"key":"6301_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/S0969-2126(01)00239-8","author":"M Karpusas","year":"1995","unstructured":"Karpusas M, Hsu Y-M, Wang J-H et al (1995) 2 \u00c5 crystal structure of an extracellular fragment of human CD40 ligand. Structure. https:\/\/doi.org\/10.1016\/S0969-2126(01)00239-8","journal-title":"Structure"},{"key":"6301_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/J.PHARMTHERA.2020.107709","volume":"219","author":"TT Tang","year":"2021","unstructured":"Tang TT, Cheng X, Truong B et al (2021) Molecular basis and therapeutic implications of CD40\/CD40L immune checkpoint. Pharmacol Ther 219:107709. https:\/\/doi.org\/10.1016\/J.PHARMTHERA.2020.107709","journal-title":"Pharmacol Ther"},{"key":"6301_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/357080A0","volume":"357","author":"RJ Armitage","year":"1992","unstructured":"Armitage RJ, Fanslow WC, Strockbine L et al (1992) Molecular and biological characterization of a murine ligand for CD40. Nature 357:80\u201382. https:\/\/doi.org\/10.1038\/357080A0","journal-title":"Nature"},{"key":"6301_CR7","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1084\/JEM.175.4.1091","volume":"175","author":"S Lederman","year":"1992","unstructured":"Lederman S, Yellin MJ, Krichevsky A et al (1992) Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help). J Exp Med 175:1091\u20131101. https:\/\/doi.org\/10.1084\/JEM.175.4.1091","journal-title":"J Exp Med"},{"key":"6301_CR8","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/35393","volume":"391","author":"V Henn","year":"1998","unstructured":"Henn V, Slupsky JR, Gr\u00e4fe M et al (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591\u2013594. https:\/\/doi.org\/10.1038\/35393","journal-title":"Nature"},{"key":"6301_CR9","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1084\/JEM.185.12.2053","volume":"185","author":"E Carbone","year":"1997","unstructured":"Carbone E, Ruggiero G, Terrazzano G et al (1997) A new mechanism of NK cell cytotoxicity activation: the CD40\u2013CD40 ligand interaction. J Exp Med 185:2053. https:\/\/doi.org\/10.1084\/JEM.185.12.2053","journal-title":"J Exp Med"},{"key":"6301_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/365340A0","volume":"365","author":"JF Gauchat","year":"1993","unstructured":"Gauchat JF, Henchoz S, Mazzei G et al (1993) Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365:340\u2013343. https:\/\/doi.org\/10.1038\/365340A0","journal-title":"Nature"},{"key":"6301_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115858","author":"AH Wagner","year":"2023","unstructured":"Wagner AH, Klersy A, Sultan CS, Hecker M (2023) Potential role of soluble CD40 receptor in chronic inflammatory diseases. Biochem Pharmacol. https:\/\/doi.org\/10.1016\/j.bcp.2023.115858","journal-title":"Biochem Pharmacol"},{"key":"6301_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2025.100288","author":"M Mabrouk","year":"2025","unstructured":"Mabrouk M, Wahnou H, Merhi Y et al (2025) The role of soluble CD40L in autoimmune diseases. J Transl Autoimmun. https:\/\/doi.org\/10.1016\/j.jtauto.2025.100288","journal-title":"J Transl Autoimmun"},{"key":"6301_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jlb.67.1.2","volume":"67","author":"G Van Kooten","year":"2000","unstructured":"Van Kooten G, Banchereau J (2000) CD40-CD40 ligand. J Leukoc Biol 67:2\u201317. https:\/\/doi.org\/10.1002\/jlb.67.1.2","journal-title":"J Leukoc Biol"},{"key":"6301_CR14","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1126\/science.7679801","volume":"259","author":"R Cutler Allen","year":"1993","unstructured":"Cutler Allen R, Armitage RJ, Ellen Conley M et al (1993) CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259:990\u2013993. https:\/\/doi.org\/10.1126\/science.7679801","journal-title":"Science"},{"key":"6301_CR15","doi-asserted-by":"publisher","first-page":"556","DOI":"10.4049\/jimmunol.155.2.556","volume":"155","author":"S Han","year":"1995","unstructured":"Han S, Hathcock K, Zheng B et al (1995) Cellular interaction in germinal centers roles of CD40 ligand and B7-2 in established germinal centers. J Immunol 155:556\u2013567. https:\/\/doi.org\/10.4049\/jimmunol.155.2.556","journal-title":"J Immunol"},{"key":"6301_CR16","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1084\/jem.180.4.1263","volume":"180","author":"C Caux","year":"1994","unstructured":"Caux C, Massacrier C, Vanbervliet B et al (1994) Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180:1263\u20131272. https:\/\/doi.org\/10.1084\/jem.180.4.1263","journal-title":"J Exp Med"},{"key":"6301_CR17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/72162","volume":"6","author":"T Kawai","year":"2000","unstructured":"Kawai T, Andrews D, Colvin RB et al (2000) Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med 6:114. https:\/\/doi.org\/10.1038\/72162","journal-title":"Nat Med"},{"key":"6301_CR18","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nbt0897-772","volume":"15","author":"K Nord","year":"1997","unstructured":"Nord K, Gunneriusson E, Ringdahl J et al (1997) Binding proteins selected from combinatorial libraries of an \u03b1-helical bacterial receptor domain. Nat Biotechnol 15:772\u2013777. https:\/\/doi.org\/10.1038\/nbt0897-772","journal-title":"Nat Biotechnol"},{"key":"6301_CR19","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.copbio.2011.06.002","volume":"22","author":"J L\u00f6fblom","year":"2011","unstructured":"L\u00f6fblom J, Frejd FY, St\u00e5hl S (2011) Non-immunoglobulin based protein scaffolds. Curr Opin Biotechnol 22:843\u2013848. https:\/\/doi.org\/10.1016\/j.copbio.2011.06.002","journal-title":"Curr Opin Biotechnol"},{"key":"6301_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.149534","author":"L Parks","year":"2024","unstructured":"Parks L, Ek M, St\u00e5hl S, L\u00f6fblom J (2024) Investigation of an AIDA-I based expression system for display of various affinity proteins on Escherichia coli. Biochem Biophys Res Commun. https:\/\/doi.org\/10.1016\/j.bbrc.2024.149534","journal-title":"Biochem Biophys Res Commun"},{"key":"6301_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/bs.ircmb.2022.03.008","volume":"369","author":"M Compte","year":"2022","unstructured":"Compte M, Sanz L, \u00c1lvarez-Vallina L (2022) Applications of trimerbodies in cancer immunotherapy. Int Rev Cell Mol Biol 369:71\u201387. https:\/\/doi.org\/10.1016\/bs.ircmb.2022.03.008","journal-title":"Int Rev Cell Mol Biol"},{"key":"6301_CR22","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1377874","author":"SL Harwood","year":"2018","unstructured":"Harwood SL, Alvarez-Cienfuegos A, Nu\u00f1ez-Prado N et al (2018) ATTACK, a novel bispecific T cell-recruiting antibody with trivalent EGFR binding and monovalent CD3 binding for cancer immunotherapy. Oncoimmunology. https:\/\/doi.org\/10.1080\/2162402X.2017.1377874","journal-title":"Oncoimmunology"},{"key":"6301_CR23","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1007\/s00262-023-03474-8","volume":"72","author":"C Battin","year":"2023","unstructured":"Battin C, De Sousa Linhares A, Leitner J et al (2023) Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents. Cancer Immunol Immunother 72:3029\u20133043. https:\/\/doi.org\/10.1007\/s00262-023-03474-8","journal-title":"Cancer Immunol Immunother"},{"key":"6301_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/srep28643","author":"A Alvarez-Cienfuegos","year":"2016","unstructured":"Alvarez-Cienfuegos A, Nu\u00f1ez-Prado N, Compte M et al (2016) Intramolecular trimerization, a novel strategy for making multispecific antibodies with controlled orientation of the antigen binding domains. Sci Rep. https:\/\/doi.org\/10.1038\/srep28643","journal-title":"Sci Rep"},{"key":"6301_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.matbio.2010.09.005","volume":"30","author":"JA Wirz","year":"2011","unstructured":"Wirz JA, Boudko SP, Lerch TF et al (2011) Crystal structure of the human collagen XV trimerization domain: a potent trimerizing unit common to multiplexin collagens. Matrix Biol 30:9\u201315. https:\/\/doi.org\/10.1016\/j.matbio.2010.09.005","journal-title":"Matrix Biol"},{"key":"6301_CR26","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/protein\/gzn028","volume":"21","author":"A Jonsson","year":"2008","unstructured":"Jonsson A, Dogan J, Herne N et al (2008) Engineering of a femtomolar affinity binding protein to human serum albumin. Protein Eng Des Sel 21:515\u2013527. https:\/\/doi.org\/10.1093\/protein\/gzn028","journal-title":"Protein Eng Des Sel"},{"key":"6301_CR27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jmb.2009.07.057","volume":"392","author":"SP Boudko","year":"2009","unstructured":"Boudko SP, Sasaki T, Engel J et al (2009) Crystal structure of human collagen XVIII trimerization domain: a novel collagen trimerization fold. J Mol Biol 392:787\u2013802. https:\/\/doi.org\/10.1016\/j.jmb.2009.07.057","journal-title":"J Mol Biol"},{"key":"6301_CR28","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1182\/blood-2007-03-081299","volume":"110","author":"Y Koguchi","year":"2007","unstructured":"Koguchi Y, Thauland TJ, Slifka MK, Parker DC (2007) Preformed CD40 ligand exists in secretory lysosomes in effector and memory CD4+ T cells and is quickly expressed on the cell surface in an antigen-specific manner. Blood 110:2520\u20132527. https:\/\/doi.org\/10.1182\/blood-2007-03-081299","journal-title":"Blood"},{"key":"6301_CR29","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.tibtech.2017.04.007","volume":"35","author":"S St\u00e5hl","year":"2017","unstructured":"St\u00e5hl S, Gr\u00e4slund T, Eriksson Karlstr\u00f6m A et al (2017) Affibody molecules in biotechnological and medical applications. Trends Biotechnol 35:691\u2013712. https:\/\/doi.org\/10.1016\/j.tibtech.2017.04.007","journal-title":"Trends Biotechnol"},{"key":"6301_CR30","doi-asserted-by":"publisher","first-page":"11925","DOI":"10.1021\/jacs.4c17452","volume":"147","author":"CJ Sadler","year":"2025","unstructured":"Sadler CJ, Creamer A, Giang KA et al (2025) Adding a twist to lateral flow immunoassays: a direct replacement of antibodies with helical affibodies, from selection to application. J Am Chem Soc 147:11925\u201311940. https:\/\/doi.org\/10.1021\/jacs.4c17452","journal-title":"J Am Chem Soc"},{"key":"6301_CR31","doi-asserted-by":"publisher","first-page":"11226","DOI":"10.1074\/jbc.M110.208215","volume":"286","author":"HJ An","year":"2011","unstructured":"An HJ, Kim YJ, Song DH et al (2011) Crystallographic and mutational analysis of the CD40-CD154 complex and its implications for receptor activation. J Biol Chem 286:11226\u201311235. https:\/\/doi.org\/10.1074\/jbc.M110.208215","journal-title":"J Biol Chem"},{"key":"6301_CR32","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.4049\/jimmunol.147.10.3389","volume":"147","author":"MJ Yellin","year":"1991","unstructured":"Yellin MJ, Lee JJ, Chess L, Lederman S (1991) A human CD4- T cell leukemia subclone with contact-dependent helper function. J Immunol 147:3389\u20133395. https:\/\/doi.org\/10.4049\/jimmunol.147.10.3389","journal-title":"J Immunol"},{"key":"6301_CR33","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/biot.201100129","volume":"6","author":"J L\u00f6fblom","year":"2011","unstructured":"L\u00f6fblom J (2011) Bacterial display in combinatorial protein engineering. Biotechnol J 6:1115\u20131129. https:\/\/doi.org\/10.1002\/biot.201100129","journal-title":"Biotechnol J"}],"updated-by":[{"DOI":"10.1007\/s00018-026-06384-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000}}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-026-06301-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06301-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06301-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T05:29:43Z","timestamp":1786512583000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-026-06301-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6301"],"URL":"https:\/\/doi.org\/10.1007\/s00018-026-06301-2","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised due to changes in authorship order. Now, it has been updated. The original article has been corrected.","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":10,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":11,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00018-026-06384-x","URL":"https:\/\/doi.org\/10.1007\/s00018-026-06384-x","order":13,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no competing interests to disclose.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"262"}}